ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.84B
- P/E ratio
- —
- EPS
- —
- Volume
- 407,958
- 52-week high
- —
- 52-week low
- —
- Open
- $79.11
- Day high
- $79.49
- Day low
- $77.62
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $883.37M | $78.34M | $3.32 |
| 2024 | $614.38M | -$18.52M | -$1.04 |
| 2023 | $486.82M | $18.78M | $0.85 |
| 2022 | $316.39M | -$47.9M | -$3.05 |
| 2021 | $216.14M | -$42.6M | -$3.40 |
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
- CEO
- Nikhil Lalwani
- Employees
- 970
- Country
- US
- IPO date
- May 5, 2000
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is ANI Pharmaceuticals, Inc.'s stock price today?
- ANIP is trading at $77.72 as of Jul 20, 2026.
- What is ANI Pharmaceuticals, Inc.'s market cap?
- ANI Pharmaceuticals, Inc. (ANIP) has a market capitalization of $1.84B.
- Does ANI Pharmaceuticals, Inc. pay a dividend?
- ANI Pharmaceuticals, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is ANI Pharmaceuticals, Inc. in?
- ANI Pharmaceuticals, Inc. operates in the Healthcare sector.